Patel Chirag G, Mendonza Anisha E, Akhlaghi Fatemeh, Majid Oneeb, Trull Andrew K, Lee Terry, Holt David W
Department of Applied Pharmaceutical Sciences, Clinical Pharmacokinetics Research Laboratory, College of Pharmacy, 41 Lower College Road, University of Rhode Island, Kingston, RI 02881, USA.
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):287-94. doi: 10.1016/j.jchromb.2004.10.004.
Two simple, sensitive and reproducible methods for determination of total mycophenolic acid (MPA) and its glucuronide metabolite (MPAG) as well as unbound MPA (fMPA) was developed by the use of HPLC-UV and LC-MS/MS methods, respectively. For the total MPA/MPAG method, the analytes were extracted using Isolute C(2) solid-phase extraction (SPE) cartridges and analyzed at 254 nm over a Zorbax Rx C(8) column (150 mm x 4.6 mm, 5 microm). The mobile phase was a gradient mixture of methanol and water (containing 0.1% (v/v) phosphoric acid). The total run time was 18 min and the extraction recovery was 77% for MPA and 84% for MPAG. The method was precise and accurate with a lower limit of quantification (LLOQ) of 0.5 mg/l for MPA and 5.0 mg/l for MPAG. For the fMPA method, plasma was subjected to ultrafiltration followed by SPE using C(18) cartridges. Analytical column was the same as the HPLC-UV method and the mobile phase was a gradient composition of methanol:0.05% formic acid with a flow rate of 0.6 ml/min for the first 3 min and 0.7 ml for the last 4 min. The chromatographic method separated MPA from its metabolites MPAG and Acyl-MPAG. Mass transitions in negative ionization mode for MPA and the internal standard, indomethacin were m/z: 319-->190.9 and m/z: 356-->312.2, respectively. The assay was linear in the concentration range of 1-1000 microg/l for fMPA with a LLOQ of 1 microg/l and an accuracy of >95%. The two methods reported have an adequate degree of robustness and dynamic concentration range for the measurement of MPA, MPAG and fMPA for therapeutic drug monitoring purposes or pharmacokinetics investigations.
分别采用高效液相色谱 - 紫外检测法(HPLC - UV)和液相色谱 - 串联质谱法(LC - MS/MS)开发了两种简单、灵敏且可重复的方法,用于测定霉酚酸(MPA)及其葡糖醛酸代谢物(MPAG)以及游离MPA(fMPA)。对于总MPA/MPAG方法,使用Isolute C(2) 固相萃取(SPE)柱提取分析物,并在Zorbax Rx C(8) 柱(150 mm×4.6 mm,5 µm)上于254 nm处进行分析。流动相为甲醇和水的梯度混合物(含0.1%(v/v)磷酸)。总运行时间为18分钟,MPA的提取回收率为77%,MPAG的提取回收率为84%。该方法精确且准确,MPA的定量下限(LLOQ)为0.5 mg/l,MPAG的定量下限为5.0 mg/l。对于fMPA方法,血浆先进行超滤,然后使用C(18) 柱进行SPE。分析柱与HPLC - UV方法相同,流动相为甲醇:0.05%甲酸的梯度组合物,前3分钟流速为0.6 ml/min,最后4分钟流速为0.7 ml/min。该色谱方法将MPA与其代谢物MPAG和酰基 - MPAG分离。MPA和内标吲哚美辛在负离子模式下的质量跃迁分别为m/z: 319→190.9和m/z: 356→312.2。该测定法在fMPA浓度范围1 - 1000 μg/l内呈线性,LLOQ为1 μg/l,准确度>95%。所报道的这两种方法对于治疗药物监测目的或药代动力学研究中MPA、MPAG和fMPA的测量具有足够的稳健性和动态浓度范围。